Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures

D. B. Cotton, M. Hallak, C. Janusz, S. M. Irtenkauf, Robert F Berman

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Objective: The objective of this study was to determine if magnesium sulfate's central anticonvulsant activity is effective against N-methyl-D-aspartate-induced seizures. Study design: In two separate experiments we investigated magnesium sulfate's ability to inhibit N-methyl-D-aspartate-induced hippocampal seizures in rats. In the first experiment magnesium sulfate was administered peripherally before an intracranial injection of 20 μg of N-methyl-D-aspartate. In the second experiment magnesium sulfate was injected intracranially concurrently with N-methyl-D-aspartate. The ability of magnesium sulfate to suppress N-methyl-D-aspartate-induced seizure activity under both conditions was assessed. Results: Peripherally administered magnesium sulfate significantly increased the latency from the time of an N-methyl-D-aspartate injection to the first seizure both by acute injection and after 2 hours of sustained elevation of serum magnesium levels when compared with saline solution-injected controls (p < 0.01). The duration of the first seizure was also significantly reduced. Intracranially administered magnesium sulfate significantly (p < 0.01) increased the seizure latency period by 120%. Overall, central magnesium sulfate prevented seizure activity in 40% of the animals (p < 0.01). Conclusion: Magnesium sulfate has a central anticonvulsant action on N-methyl-D-aspartate-induced seizures in this rat model of hippocampal seizures.

Original languageEnglish (US)
Pages (from-to)974-978
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume168
Issue number3 I
StatePublished - 1993
Externally publishedYes

Fingerprint

Magnesium Sulfate
N-Methylaspartate
Anticonvulsants
Seizures
Injections
Sodium Chloride
Magnesium

Keywords

  • hippocampus
  • magnesium sulfate
  • N-methyl-D-aspartate (NMDA)
  • seizures

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures. / Cotton, D. B.; Hallak, M.; Janusz, C.; Irtenkauf, S. M.; Berman, Robert F.

In: American Journal of Obstetrics and Gynecology, Vol. 168, No. 3 I, 1993, p. 974-978.

Research output: Contribution to journalArticle

Cotton, D. B. ; Hallak, M. ; Janusz, C. ; Irtenkauf, S. M. ; Berman, Robert F. / Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures. In: American Journal of Obstetrics and Gynecology. 1993 ; Vol. 168, No. 3 I. pp. 974-978.
@article{467f68b8c2a54f368a5db453aa0b1c09,
title = "Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures",
abstract = "Objective: The objective of this study was to determine if magnesium sulfate's central anticonvulsant activity is effective against N-methyl-D-aspartate-induced seizures. Study design: In two separate experiments we investigated magnesium sulfate's ability to inhibit N-methyl-D-aspartate-induced hippocampal seizures in rats. In the first experiment magnesium sulfate was administered peripherally before an intracranial injection of 20 μg of N-methyl-D-aspartate. In the second experiment magnesium sulfate was injected intracranially concurrently with N-methyl-D-aspartate. The ability of magnesium sulfate to suppress N-methyl-D-aspartate-induced seizure activity under both conditions was assessed. Results: Peripherally administered magnesium sulfate significantly increased the latency from the time of an N-methyl-D-aspartate injection to the first seizure both by acute injection and after 2 hours of sustained elevation of serum magnesium levels when compared with saline solution-injected controls (p < 0.01). The duration of the first seizure was also significantly reduced. Intracranially administered magnesium sulfate significantly (p < 0.01) increased the seizure latency period by 120{\%}. Overall, central magnesium sulfate prevented seizure activity in 40{\%} of the animals (p < 0.01). Conclusion: Magnesium sulfate has a central anticonvulsant action on N-methyl-D-aspartate-induced seizures in this rat model of hippocampal seizures.",
keywords = "hippocampus, magnesium sulfate, N-methyl-D-aspartate (NMDA), seizures",
author = "Cotton, {D. B.} and M. Hallak and C. Janusz and Irtenkauf, {S. M.} and Berman, {Robert F}",
year = "1993",
language = "English (US)",
volume = "168",
pages = "974--978",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3 I",

}

TY - JOUR

T1 - Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures

AU - Cotton, D. B.

AU - Hallak, M.

AU - Janusz, C.

AU - Irtenkauf, S. M.

AU - Berman, Robert F

PY - 1993

Y1 - 1993

N2 - Objective: The objective of this study was to determine if magnesium sulfate's central anticonvulsant activity is effective against N-methyl-D-aspartate-induced seizures. Study design: In two separate experiments we investigated magnesium sulfate's ability to inhibit N-methyl-D-aspartate-induced hippocampal seizures in rats. In the first experiment magnesium sulfate was administered peripherally before an intracranial injection of 20 μg of N-methyl-D-aspartate. In the second experiment magnesium sulfate was injected intracranially concurrently with N-methyl-D-aspartate. The ability of magnesium sulfate to suppress N-methyl-D-aspartate-induced seizure activity under both conditions was assessed. Results: Peripherally administered magnesium sulfate significantly increased the latency from the time of an N-methyl-D-aspartate injection to the first seizure both by acute injection and after 2 hours of sustained elevation of serum magnesium levels when compared with saline solution-injected controls (p < 0.01). The duration of the first seizure was also significantly reduced. Intracranially administered magnesium sulfate significantly (p < 0.01) increased the seizure latency period by 120%. Overall, central magnesium sulfate prevented seizure activity in 40% of the animals (p < 0.01). Conclusion: Magnesium sulfate has a central anticonvulsant action on N-methyl-D-aspartate-induced seizures in this rat model of hippocampal seizures.

AB - Objective: The objective of this study was to determine if magnesium sulfate's central anticonvulsant activity is effective against N-methyl-D-aspartate-induced seizures. Study design: In two separate experiments we investigated magnesium sulfate's ability to inhibit N-methyl-D-aspartate-induced hippocampal seizures in rats. In the first experiment magnesium sulfate was administered peripherally before an intracranial injection of 20 μg of N-methyl-D-aspartate. In the second experiment magnesium sulfate was injected intracranially concurrently with N-methyl-D-aspartate. The ability of magnesium sulfate to suppress N-methyl-D-aspartate-induced seizure activity under both conditions was assessed. Results: Peripherally administered magnesium sulfate significantly increased the latency from the time of an N-methyl-D-aspartate injection to the first seizure both by acute injection and after 2 hours of sustained elevation of serum magnesium levels when compared with saline solution-injected controls (p < 0.01). The duration of the first seizure was also significantly reduced. Intracranially administered magnesium sulfate significantly (p < 0.01) increased the seizure latency period by 120%. Overall, central magnesium sulfate prevented seizure activity in 40% of the animals (p < 0.01). Conclusion: Magnesium sulfate has a central anticonvulsant action on N-methyl-D-aspartate-induced seizures in this rat model of hippocampal seizures.

KW - hippocampus

KW - magnesium sulfate

KW - N-methyl-D-aspartate (NMDA)

KW - seizures

UR - http://www.scopus.com/inward/record.url?scp=0027462610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027462610&partnerID=8YFLogxK

M3 - Article

C2 - 8456911

AN - SCOPUS:0027462610

VL - 168

SP - 974

EP - 978

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3 I

ER -